Clinical Trials List
2012-06-01 - 2015-09-30
Phase III
Study ended4
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Chia-Chi Lin Division of Hematology & Oncology
- 陳冠宇 Division of Thoracic Medicine
- JIN-YUAN SHIH Division of Thoracic Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- 林育麟 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Thoracic Medicine
- Chong-Jen Yu Division of Thoracic Medicine
- 廖唯昱 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Chih-Teng Yu Division of Hematology & Oncology
- kang-Yun LEE Division of Thoracic Medicine
- 黃建達 Division of Thoracic Medicine
- Fu-Tsai Chung Division of Hematology & Oncology
- Chun-Hua Wang Division of Thoracic Medicine
- Po-Hao Feng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- 林慶雄 Division of Thoracic Medicine
- 紀炳銓 Division of Thoracic Medicine
- 王全正 Division of Hematology & Oncology
- 林明泰 Division of Thoracic Medicine
- 張正雄 Division of Hematology & Oncology
- 鍾智淵 Division of Hematology & Oncology
- 葉金水 Division of Thoracic Medicine
- 林聖皓 Division of Thoracic Medicine
- 林炫聿 Division of Hematology & Oncology
- 張竣期 Division of Thoracic Medicine
- 施穎銘 Division of Thoracic Medicine
- 林正純 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
490 participants
